Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmoud Aljurf

Showing results (141-150 of 403) with videos related to

Pageof 41
Sort By:
British Journal of Haematology|February 6, 2020
Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remissionMarina Díaz-Beyá, Myriam Labopin, Johan Maertens, et al.
Transplantation and Cellular Therapy|March 30, 2021
Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow TransplantationNina Worel, Bronwen E Shaw, Mahmoud Aljurf, et al.
Biotechnology Research International|March 24, 2016
Chimerism Analysis of Cell-Free DNA in Patients Treated with Hematopoietic Stem Cell Transplantation May Predict Early Relapse in Patients with Hematologic MalignanciesMahmoud Aljurf, Hala Abalkhail, Amal Alseraihy, et al.
American Journal of Hematology|July 24, 2018
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemiaFrancesco Saraceni, Eric Beohou, Myriam Labopin, et al.
American Journal of Hematology|June 15, 2017
Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSandra Eder, Jonathan Canaani, Eric Beohou, et al.
Bone Marrow Transplantation|April 20, 2020
CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overviewMohamad Mohty, Remy Dulery, Jordan Gauthier, et al.
Transplantation and Cellular Therapy|July 5, 2023
Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid LeukemiaMuhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, et al.
Ejhaem|July 18, 2022
The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor-risk cytogenetic abnormalitiesMona Hassanein, Riad El Fakih, Walid Rasheed, et al.
Haematologica|January 25, 2015
Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysisAndrea Bacigalupo, Gerard Socié, Rose Marie Hamladji, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationYi-Bin Chen, Andrew A Lane, Brent Logan, et al.
Pageof 41

Showing results (141-150 of 403) with videos related to

Sort By:
Pageof 41
British Journal of Haematology|February 6, 2020
Allogeneic stem cell transplantation in AML with t(6;9)(p23;q34);DEK-NUP214 shows a favourable outcome when performed in first complete remissionMarina Díaz-Beyá, Myriam Labopin, Johan Maertens, et al.
Transplantation and Cellular Therapy|March 30, 2021
Changes in Hematopoietic Cell Transplantation Practices in Response to COVID-19: A Survey from the Worldwide Network for Blood & Marrow TransplantationNina Worel, Bronwen E Shaw, Mahmoud Aljurf, et al.
Biotechnology Research International|March 24, 2016
Chimerism Analysis of Cell-Free DNA in Patients Treated with Hematopoietic Stem Cell Transplantation May Predict Early Relapse in Patients with Hematologic MalignanciesMahmoud Aljurf, Hala Abalkhail, Amal Alseraihy, et al.
American Journal of Hematology|July 24, 2018
Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemiaFrancesco Saraceni, Eric Beohou, Myriam Labopin, et al.
American Journal of Hematology|June 15, 2017
Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationSandra Eder, Jonathan Canaani, Eric Beohou, et al.
Bone Marrow Transplantation|April 20, 2020
CAR T-cell therapy for the management of refractory/relapsed high-grade B-cell lymphoma: a practical overviewMohamad Mohty, Remy Dulery, Jordan Gauthier, et al.
Transplantation and Cellular Therapy|July 5, 2023
Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid LeukemiaMuhammad Bilal Abid, Noel Estrada-Merly, Mei-Jie Zhang, et al.
Ejhaem|July 18, 2022
The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor-risk cytogenetic abnormalitiesMona Hassanein, Riad El Fakih, Walid Rasheed, et al.
Haematologica|January 25, 2015
Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysisAndrea Bacigalupo, Gerard Socié, Rose Marie Hamladji, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2015
Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantationYi-Bin Chen, Andrew A Lane, Brent Logan, et al.
Pageof 41